Literature DB >> 31247372

Structure-activity relationship of group A streptococcus lipopeptide vaccine candidates in trimethyl chitosan-based self-adjuvanting delivery system.

Reshma J Nevagi1, Wei Dai1, Zeinab G Khalil2, Waleed M Hussein3, Robert J Capon4, Mariusz Skwarczynski5, Istvan Toth6.   

Abstract

Synthetic peptide vaccines based on epitopes derived from the conserved region of M-protein are proving to be a realistic option for protection against group A streptococcus (GAS). However, peptide epitopes alone are poorly immunogenic due to lack of pathogen-associated structural patterns. Therefore, we developed a GAS peptide vaccine based on combined lipidic TLR 2 agonist and self-adjuvanting polymers. We synthesized three α-poly-l-glutamic acid (PGA) conjugated lipopeptides composed of 2-amino-d,l-hexadecanoic acid, GAS B-cell peptide epitope J8 (QAEDKVKQSREAKKQVEKALKQLEDKVQ) and universal T-helper epitope PADRE (AKFVAAWTLKAAA) in different spatial arrangements. The anionic lipopeptide conjugates formed nanoparticles via ionic-complexation with a cationic polymer, trimethyl chitosan (TMC). We demonstrated that the spatial arrangement of vaccine components has a significant influence on peptide conformation and particle formation and, as such, contributes to the differential efficacy and opsonin-mediated killing potential of nanovaccines. Nanoparticles carrying branched helical lipopeptide with T-helper epitope on free N-termini (NP3) stimulated the most potent humoral immune responses. Lipopeptides without TMC (LP1-LP3) and TMC nanoparticles of peptide alone (without lipid) NP (P1) were poor inducers of antibody production, indicating that both TMC and lipid are required to induce a strong opsonic immune response.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Chitosan; Group A streptococcus; Intranasal immunization; Lipopeptide; Nanoparticles; Nanovaccine; Polyglutamic acid; Spatial arrangement

Mesh:

Substances:

Year:  2019        PMID: 31247372     DOI: 10.1016/j.ejmech.2019.06.047

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

1.  Current Prospects in Peptide-Based Subunit Nanovaccines.

Authors:  Prashamsa Koirala; Sahra Bashiri; Istvan Toth; Mariusz Skwarczynski
Journal:  Methods Mol Biol       Date:  2022

2.  Liposomes for the Delivery of Lipopeptide Vaccines.

Authors:  Jieru Yang; Armira Azuar; Istvan Toth; Mariusz Skwarczynski
Journal:  Methods Mol Biol       Date:  2022

3.  Structure-Activity Relationship Studies To Identify Affinity Probes in Bis-aryl Sulfonamides That Prolong Immune Stimuli.

Authors:  Michael Chan; Fitzgerald S Lao; Paul J Chu; Jonathan Shpigelman; Shiyin Yao; Jason Nan; Fumi Sato-Kaneko; Vicky Li; Tomoko Hayashi; Maripat Corr; Dennis A Carson; Howard B Cottam; Nikunj M Shukla
Journal:  J Med Chem       Date:  2019-10-25       Impact factor: 7.446

Review 4.  A Global Review on Short Peptides: Frontiers and Perspectives.

Authors:  Vasso Apostolopoulos; Joanna Bojarska; Tsun-Thai Chai; Sherif Elnagdy; Krzysztof Kaczmarek; John Matsoukas; Roger New; Keykavous Parang; Octavio Paredes Lopez; Hamideh Parhiz; Conrad O Perera; Monica Pickholz; Milan Remko; Michele Saviano; Mariusz Skwarczynski; Yefeng Tang; Wojciech M Wolf; Taku Yoshiya; Janusz Zabrocki; Piotr Zielenkiewicz; Maha AlKhazindar; Vanessa Barriga; Konstantinos Kelaidonis; Elham Mousavinezhad Sarasia; Istvan Toth
Journal:  Molecules       Date:  2021-01-15       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.